Navigation Links
Triclosan needs to be monitored
Date:10/25/2012

This press release is available in German.

Leipzig. Researchers from Germany and Slovakia have pointed out that the chemical triclosan is one of those particularly harmful substances for the ecological status of rivers that are still not sufficiently monitored. With extensive monitoring conducted in the Elbe river basin that was more comprehensive than standard monitoring procedures, concentrations of the chemical at numerous test sites exceeded the predicted no-effect concentration (PNEC) for algal communities up to a factor of twelve. From the 500 river basin-specific pollutants investigated, triclosan (normally used as an anti-bacterial agent) ranked sixth as one of the most particularly harmful substances in Europe. It is therefore imperative to include this substance in routine monitoring programmes at the European scale, according to what researchers from the Helmholtz Centre for Environmental Research (UFZ) and the Environmental Institute in Slovakia have written in the journal Environmental Science Pollution Research".

It is intended that the list of priority substances that have to be monitored by the authorities in Europe will be extended from its current 33 to 45 substances. The chemical triclosan is not one of these new candidates however. This chemical has been on the market since 1972 and it was not until 1998 that the first serious effects were discovered. Until now triclosan has been used as an antibacterial and antifungal agent in personal care products (e.g. toothpaste) and sportswear. Scientists were also very concerned about the fact that nowadays triclosan cannot only be detected in organisms living in wastewater but also in human plasma and in breast milk. Therefore, harmful effects extending beyond water organisms cannot be excluded.

Approximately 350 tons of triclosan were used in the European Union in 2005. However, it is still not monitored in many parts of Europe. " Substances that are not on the list of priority substances do not have to be monitored and substances that are not monitored are usually not included on the list, because too little is known about their environmental relevance", Dr. Peter von der Ohe from the UFZ portrays this dilemma. Within the EU-research project MODELKEY scientists have therefore been closely examining several hundred pollutants in different European river catchment areas and have come up with suggestions on how the monitoring of rivers for chemicals could be improved.
'/>"/>

Contact: Tilo Arnhold
presse@ufz.de
49-341-235-1635
Helmholtz Association of German Research Centres
Source:Eurekalert  

Related biology news :

1. In an uncertain world, Navy needs science and technology collaboration, chief says
2. Food science poised to help address needs of aging population
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Triclosan needs to be monitored
(Date:2/16/2017)... 2017  Genos, a community for personal genetic ... received Laboratory Accreditation from the College of American ... laboratories that meet stringent requirements around quality, accuracy ... "Genos is committed to maintaining the ... honored to be receiving CAP accreditation," said ...
(Date:2/10/2017)... Feb 10, 2017 Research and ... "Personalized Medicine - Scientific and Commercial Aspects" to ... ... Diagnosis is integrated with therapy for selection of treatment as ... detection and prevention of disease in modern medicine. Biochip/microarray technologies ...
(Date:2/8/2017)... 2017 Report Highlights ... The global synthetic-biology market reached nearly ... 2021, growing at a compound annual growth rate (CAGR) of ... the global markets for synthetic biology. - Analyses of global ... projections of compound annual growth rates (CAGRs) through 2021. - ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... 23, 2017 In today,s pre-market ... in the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), ... MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." ... report at: ...
(Date:3/22/2017)... , March 22, 2017  UBM and ... to announce their extended partnership and the third ... headlined by the 21 st Annual MassMEDIC ... taking place May 3-4, 2017. ... Technology Association (ADVAMED) President and CEO, Scott ...
(Date:3/22/2017)... , March 22, 2017 MarketNewsUpdates.com ... ... cancer conditions are being pressured as of late due to ... cancer pain management has a dramatic impact on patient,s quality ... and development activities for identifying new forms of opioid formulations ...
(Date:3/22/2017)... ... March 21, 2017 , ... Okyanos Cell Therapy has announced Tallahassee, FL ... live events series, “Stem Cell Therapy: The Next Phase in the Evolution of Medicine.” ... Stem Cell Research and Therapy Act, Okyanos maintains a mission to help “no-option” ...
Breaking Biology Technology: